Excellent 4.6 out of 5
Solvents & Industrial Byproducts

N-Acetyl (3,4-Dihydroxybutyl) Cysteine Environmental Toxin Test

This urine test measures N‑acetyl‑(3,4‑dihydroxybutyl)‑cysteine (DHBMA), a biomarker of 1,3‑butadiene exposure from cigarette smoke, traffic exhaust, and industrial emissions. Identifying and reducing this toxic exposure can help lower your risk of certain cancers and related cardiovascular and respiratory problems.

With Superpower, you have access to a comprehensive range of biomarker tests.

Test for N-Acetyl (3,4-Dihydroxybutyl) Cysteine
Cancel anytime
HSA/FSA eligible
Results in a week
Physician reviewed

Every result is checked

·
CLIA-certified labs

Federal standard for testing

·
HIPAA compliant

Your data is 100% secure

Key Insights

  • See your current exposure to 1,3‑butadiene via its urinary metabolite N‑Acetyl (3,4‑Dihydroxybutyl) Cysteine and how it compares with typical levels.
  • Identify meaningful exposure patterns and potential sources (e.g., tobacco smoke, traffic exhaust, industrial emissions, indoor air, high‑heat combustion).
  • Clarify whether 1,3‑butadiene exposure could be adding to symptom clusters or system stress (respiratory irritation, headaches, oxidative stress, hematologic risk).
  • Support reproductive planning or pregnancy safety by checking for elevations during sensitive life stages.
  • Track trends over time after changing environments, products, or occupational practices.
  • Inform conversations with your clinician about additional evaluations, workplace considerations, or targeted exposure‑reduction strategies.

What is N‑Acetyl (3,4‑Dihydroxybutyl) Cysteine?

N‑Acetyl (3,4‑Dihydroxybutyl) Cysteine is a mouthful, so here’s the plain version: it’s a mercapturic acid in urine that your body makes after encountering 1,3‑butadiene, a common industrial and urban air pollutant. 1,3‑butadiene is a gas used in making synthetic rubber and can be found in vehicle exhaust and tobacco smoke. The body processes that gas, couples reactive byproducts to glutathione (a protective antioxidant), and ultimately excretes these “tagged” fragments in urine. This specific metabolite is often shortened to DHBMA. Labs measure DHBMA in urine, typically by LC‑MS/MS, to reflect recent exposure rather than long‑term body burden.

Why it matters: 1,3‑butadiene can form reactive epoxides that interact with cellular DNA and proteins. Your detox systems—particularly the liver’s phase I and phase II enzymes and the glutathione pathway—work to neutralize and clear these. Elevated DHBMA suggests the body has been busy processing 1,3‑butadiene. While 1,3‑butadiene does not bioaccumulate like some persistent chemicals, repeated or higher exposures can increase system stress over time. Epidemiology and biomonitoring research link higher levels to tobacco smoke and certain workplaces, with regulatory agencies classifying 1,3‑butadiene as a human carcinogen, though individual risk depends on dose, duration, and co‑exposures.

Why Is It Important to Test For N‑Acetyl (3,4‑Dihydroxybutyl) Cysteine?

Because DHBMA tracks your recent 1,3‑butadiene exposure, a single test can help distinguish a one‑off encounter—think a long day in traffic near idling buses—from an ongoing source like regular secondhand smoke or occupational contact. That clarity can explain why some people notice respiratory irritation, headaches, or fatigue after certain environments, and it can help pinpoint whether the likely contributor is urban air, a specific building, or a work process. Testing is especially informative if you’re pregnant or planning pregnancy, live with smokers, commute through heavy traffic, or work around combustion or synthetic rubber manufacturing. It also helps separate incidental contact from sustained exposure that may warrant closer look with your clinician.

Big picture, DHBMA results become more meaningful when viewed alongside patterns in other volatile organic compound (VOC) metabolites, general health markers, and your symptom story. Environmental exposures rarely act in isolation. Watching trends—rather than reacting to a single value—helps you see whether changes in home ventilation, commuting patterns, or workplace practices align with lower biomarker levels. That context is what turns a lab number into health insight.

What Insights Will I Get From an N‑Acetyl (3,4‑Dihydroxybutyl) Cysteine Test?

Labs typically report DHBMA as a urine concentration, often adjusted to creatinine to account for hydration. Reference ranges are population‑based, not “optimal,” and they describe what’s commonly seen in the general public. For environmental toxins like 1,3‑butadiene, lower values are generally preferable when feasible. Interpretation benefits from knowing your recent exposures—travel, commuting, secondhand smoke, workplace tasks—and, when possible, from repeat testing to confirm a pattern.

Relatively lower DHBMA values usually indicate limited recent 1,3‑butadiene exposure and a lower likelihood of short‑term system stress from this source. That often aligns with non‑smoking households, good ventilation, and limited time in high‑traffic or industrial settings. For pregnancy and early childhood—life stages more sensitive to air pollutants—keeping exposure in the lower end of population norms is generally considered prudent, though individual decisions should be made with a clinician.

Relatively higher DHBMA suggests recent or ongoing exposure. That can reflect tobacco smoke (active or secondhand), urban traffic density, or specific work environments. Biologically, it means the liver and glutathione pathways are processing more of this pollutant, and the kidneys are clearing the resulting conjugates. People may notice respiratory irritation or headaches in parallel with co‑exposures, but the metabolite alone does not diagnose a condition. Because hydration, timing, and lab methods influence results, confirmation with trend data and context is key—especially if values are unexpectedly elevated.

In the end, DHBMA is most useful alongside related markers and your real life. Pairing it with other VOC metabolites, tobacco smoke biomarkers, and general health indicators helps separate transient spikes from persistent exposure patterns. Over time, that combined view supports smarter environmental choices and more focused clinical discussions without overinterpreting any single result.

How the Test Works and What Affects Results

Where Exposure Commonly Comes From

Typical sources include tobacco smoke (active and secondhand), vehicle exhaust in dense traffic, emissions from synthetic rubber production, and other high‑heat combustion settings. Everyday examples: refueling near diesel vehicles, standing close to a smoker outdoors, or spending hours along a busy roadway. Indoor air can contribute if ventilation is poor and a source is present. Diet is not a major driver compared with inhalation for 1,3‑butadiene.

Who Might Consider Testing

People living with smokers, commuting through heavy traffic, working in or near rubber manufacturing or combustion processes, or navigating pregnancy planning may find DHBMA testing clarifies exposure. It can also be helpful when unexplained headaches or irritant symptoms seem tied to specific places or routines, or when you are evaluating the impact of environmental changes and want objective feedback.

How to Think About Results with Your Clinician

Treat the number as a data point, not a diagnosis. Discuss recent exposures, household and workplace context, and whether other biomarkers might round out the picture. In some cases, looking at additional VOC metabolites helps differentiate broad air pollution exposure from a more specific source. Your clinician can also interpret levels in light of overall health, pregnancy status, and any co‑existing conditions, keeping in mind that research continues to evolve.

Limitations to Keep in Mind

DHBMA reflects recent exposure and cannot pinpoint a single source by itself. Hydration and collection timing influence results. Population ranges describe what is common, not necessarily what is ideal. And while 1,3‑butadiene is a known concern at higher or prolonged exposures, individual risk depends on dose, duration, and co‑exposures—more research is ongoing to refine those relationships. That’s why trend tracking and clinical context are so important.

Superpower also tests for

See more diseases

Frequently Asked Questions About

What is a N-Acetyl (3,4-Dihydroxybutyl) Cysteine test?

This test measures urinary N‑acetyl(3,4‑dihydroxybutyl)cysteine, a mercapturic‑acid metabolite that functions as an exposure marker rather than a parent compound. Its presence reflects glutathione‑mediated detoxification of reactive electrophilic intermediates derived from certain parent volatile organic compounds, and is used to estimate recent exposure and metabolic processing of those chemicals.

Should I test for N-Acetyl (3,4-Dihydroxybutyl) Cysteine?

N-Acetyl (3,4-Dihydroxybutyl) Cysteine (DHBMA) is a urinary marker of 1,3-butadiene exposure—most commonly from cigarette smoke, vehicle exhaust, and certain petrochemical or rubber-industry settings.

Testing is most useful if you smoke, have significant secondhand smoke exposure, live/work near heavy traffic or industrial sources, or need to document workplace exposure. For better specificity, consider pairing it with MHBMA (another 1,3-butadiene metabolite).

If results are elevated, focus on reducing exposures and re-test to confirm trends. This test doesn’t diagnose disease—interpret alongside your exposure history and clinical guidance.

How often should I test for N-Acetyl (3,4-Dihydroxybutyl) Cysteine?

Obtain a baseline test once to assess exposure to N-Acetyl (3,4-Dihydroxybutyl) Cysteine; if levels are elevated, perform periodic follow-up testing (for example, every few months) until levels decline or a clinician advises otherwise. Retest after meaningful lifestyle or environmental changes—such as after changing household products, altering work tasks or removing a known exposure source—or following detoxification efforts, and whenever new symptoms arise; monitoring frequency should be individualized based on exposure risk and clinical guidance.

What can affect N-Acetyl (3,4-Dihydroxybutyl) Cysteine test results?

Test results for N‑Acetyl (3,4‑Dihydroxybutyl) Cysteine can be affected by the timing of sample collection (levels vary with time after exposure), recent exposures from food, air, water or consumer products, individual metabolism (genetic and health-related differences in how the body processes the compound), hydration status (dilution or concentration of urine samples), and the sample type collected (urine versus blood can show different concentrations); additionally certain medications or supplements may alter readings.

Are there any preparations needed before testing N-Acetyl (3,4-Dihydroxybutyl) Cysteine levels?

Fasting is generally not required for N‑Acetyl (3,4‑Dihydroxybutyl) Cysteine testing; many labs accept a random (spot) urine sample. A first‑morning urine can be recommended when laboratories want a more concentrated and consistent sample, but follow the specific instructions from the testing provider or clinician.

Where possible, avoid known or obvious exposures to the chemical being measured and related sources for 24–48 hours before sampling (for example avoid occupational contact, recent smoking, or use of products likely to contain the compound). Before testing, note and report any recent product use or environmental contact — including plastics, personal care items (lotions, cosmetics, fragrances), pesticides, solvents, adhesives, cleaning products or other potential sources — with approximate timing, as this information helps interpret results.

How accurate is N-Acetyl (3,4-Dihydroxybutyl) Cysteine testing?

N-Acetyl (3,4-Dihydroxybutyl) Cysteine testing is generally reliable for detecting recent exposure because it measures a specific mercapturic acid metabolite excreted after uptake and metabolism; it reflects recent metabolism/excretion rather than long‑term body burden. Positive results indicate that the body has processed the parent compound within the past hours to days, while low or absent levels do not rule out past or chronic exposures that occurred well before sampling.

Accuracy depends strongly on sample timing (collecting urine or blood within the appropriate window after exposure), the laboratory method used (targeted mass spectrometry methods such as LC‑MS/MS or high‑resolution MS provide greater sensitivity and specificity than immunoassays), and consistent, proper collection and handling (correct matrix, storage, avoidance of contamination, and use of normalization like creatinine when appropriate). When those factors are controlled, the test is a robust indicator of recent exposure; when they are not, results can be misleading.

What happens if my N-Acetyl (3,4-Dihydroxybutyl) Cysteine levels are outside the optimal or reference range?

High levels of N‑Acetyl (3,4‑Dihydroxybutyl) Cysteine typically mean recent or ongoing exposure to the parent chemical or slower removal from the body — for example from environmental or workplace sources, contaminated food/water, or reduced detox/clearance function. Elevated results suggest a higher body burden and usually prompt follow‑up: repeat testing, review of possible exposure sources, and comparison with other toxin and organ‑function markers to assess risk and need for intervention.

Low or below‑reference levels usually indicate little or no recent exposure or efficient clearance, but they don’t prove there was never exposure or rule out past accumulation. Results should always be interpreted in context — with other toxin measurements, lifestyle (occupation, smoking, diet), and health markers — and discussed with a clinician who can recommend next steps such as exposure assessment, monitoring, or further testing.

How do I interpret my N-Acetyl (3,4-Dihydroxybutyl) Cysteine test results?

N-Acetyl (3,4-Dihydroxybutyl) Cysteine in urine is a mercapturic acid-type metabolite that generally indicates recent exposure to a specific electrophilic/toxicant and ongoing Phase II detoxification (glutathione conjugation followed by N‑acetylation). A value above your lab’s reference range suggests greater recent exposure or a higher detoxification burden; a value within or below the reference range suggests little or no recent exposure or, less commonly, altered metabolism or excretion. A single result is limited—compare the numeric value and units to the laboratory’s reference interval and note whether the test was spot, 24‑hour, or creatinine‑normalized.

Interpretation is most reliable when viewed over time and in context: trends (rising or falling) indicate changing exposure or changes in metabolic/excretory capacity more clearly than a single measurement. Always review this marker alongside related toxin markers and body‑system indicators — for example liver function (conjugation capacity), kidney function (urinary excretion), and oxidative‑stress or inflammation biomarkers — and consider known exposure history (occupational, environmental, or dietary). If levels are elevated or trend upward, correlate with exposure controls, repeat testing as indicated, and discuss results with a clinician for appropriate follow‑up.

How it works

1

Test your whole body

Get a comprehensive blood draw at one of our 3,000+ partner labs or from the comfort of your own home.

2

An Actionable Plan

Easy to understand results & a clear action plan with tailored recommendations on diet, lifestyle changes, supplements and pharmaceuticals.

3

A Connected Ecosystem

You can book additional diagnostics, buy curated supplements for 20% off & pharmaceuticals within your Superpower dashboard.

Superpower tests more than 
100+ biomarkers & common symptoms

Developed by world-class medical professionals

Supported by the world’s top longevity clinicians and MDs.

Dr Anant Vinjamoori

Superpower Chief Longevity Officer, Harvard MD & MBA

A smiling woman wearing a white coat and stethoscope poses for a portrait.

Dr Leigh Erin Connealy

Clinician & Founder of The Centre for New Medicine

Man in a black medical scrub top smiling at the camera.

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

membership

$17

/month
Billed annually at $199
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.
A website displays a list of most ordered products including a ring, vitamin spray, and oil.
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.A tablet screen shows a shopping website with three most ordered products: a ring, supplement, and skincare oil.
What could cost you $15,000 is $199

Superpower
Membership

Your membership includes one comprehensive blood draw each year, covering 100+ biomarkers in a single collection
One appointment, one draw for your annual panel.
100+ labs tested per year
A personalized plan that evolves with you
Get your biological age and track your health over a lifetime
$
17
/month
billed annually
Flexible payment options
Four credit card logos: HSA/FSA Eligible, American Express, Visa, and Mastercard.
Start your Women’s Health Check
Cancel anytime
HSA/FSA eligible
Results in a week
Pricing may vary for members in New York and New Jersey **

Finally, healthcare that looks at the whole you